Evidence map›Paper›PMID 31117151›Full record

ArticleAddiction (Abingdon, England)2019

Moderators of real-world effectiveness of smoking cessation aids: a population study.

Sarah E Jackson, Daniel Kotz, Robert West, Jamie Brown

Abstract read
In one paragraph

Article in Addiction (Abingdon, England), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 59 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
59citing papers in PubMed, 5 pooled it
9.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

59 citing papers in PubMed, 5 syntheses or guidelines pooled it, 106 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Trial
  7. Trial
  8. Trial
  9. Review
  10. Trends in Single and Multiple Noncombustible Nicotine Product Use: A Population Study in England.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2025
    Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Observational
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Sarah E JacksonDepartment of Behavioural Science and Health, University College London, London, UK.ORCID 0000-0001-5658-6168
Daniel KotzDepartment of Behavioural Science and Health, University College London, London, UK.ORCID 0000-0002-9454-023X
Robert WestDepartment of Behavioural Science and Health, University College London, London, UK.ORCID 0000-0001-6398-0921
Jamie BrownDepartment of Behavioural Science and Health, University College London, London, UK.ORCID 0000-0002-2797-5428
University College London · GBHeinrich Heine University Düsseldorf · DE

Funding

Cancer Research UK 22962Cancer Research UK A22962Cancer Research UK C44576/A19501Medical Research Council MR/K023195/1
6 · The paper itself

Abstract

BACKGROUND AND

aimsUnderstanding whether and how far smokers' characteristics influence the effectiveness of treatment may be important for tailoring recommendations on cessation aids to those most likely to help the user achieve abstinence. This study aimed to estimate the effectiveness of commonly used smoking cessation aids and test whether their effectiveness differs according to cigarette addiction, socio-economic status, age or sex.

designCorrelational design using cross-sectional survey data collected monthly between 2006 and 2018.

settingEngland.

participantsA total of 18 929 adults (aged ≥ 16 years, 52.0% female) who had smoked within the previous 12 months and had made at least one quit attempt during that period. MEASUREMENTS: The outcome was self-reported abstinence from quit date to survey. Independent variables were self-reported use during the most recent quit attempt of: prescription nicotine replacement therapy (NRT), NRT over-the-counter, varenicline, bupropion, e-cigarettes, face-to-face behavioural support, telephone support, written self-help materials, websites and hypnotherapy. Moderators were cigarette addiction, social grade, age and sex.

findingsAfter adjustment for covariates and use of other cessation aids, users of e-cigarettes [odds ratio (OR) = 1.95, 95% confidence interval (CI) = 1.69-2.24] and varenicline (OR = 1.82, 95% CI = 1.51-2.21) had significantly higher odds of reporting abstinence than those who did not report use of these cessation aids. Use of prescription NRT was associated with increased abstinence in older (≥ 45 years) (OR = 1.58, 95% CI = 1.25-2.00) but not younger (< 45 years) smokers (OR = 1.09, 95% CI = 0.85-1.42). Use of websites was associated with increased abstinence in smokers from lower (OR = 2.20, 95% CI = 1.22-3.98) but not higher social grades (OR = 0.74, 95% CI = 0.40-1.38). There was little evidence of benefits of using other cessation aids.

conclusionsUse of e-cigarettes and varenicline are associated with higher abstinence rates following a quit attempt in England. Use of prescription of nicotine replacement therapy is also associated with higher abstinence rates, but only in older smokers, and use of websites only in smokers from lower socio-economic status.

Indexed as

CounselingElectronic Nicotine Delivery SystemsTobacco Use Cessation DevicesAdolescentAdultAgedAge FactorsBupropionCross-Sectional StudiesEnglandFemaleHumansHypnosisInternetMaleMiddle AgedBupropionNonprescription DrugsSmoking Cessation AgentsVareniclinebehavioural supportbupropioncessation aidse-cigarettesnicotine replacement therapyreal-world effectivenesssmoking cessationvarenicline

Identifiers

PMID31117151
PMCPMC6684357
OpenAlexW2946714077

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.